LakeShore Biopharma Co., Ltd (LSB)
NASDAQ: LSB · Real-Time Price · USD
1.725
-0.045 (-2.54%)
At close: Apr 9, 2025, 4:00 PM
1.800
+0.075 (4.35%)
After-hours: Apr 9, 2025, 4:14 PM EDT
LakeShore Biopharma Employees
LakeShore Biopharma had 758 employees as of March 31, 2024. The number of employees decreased by 15 or -1.94% compared to the previous year.
Employees
758
Change (1Y)
-15
Growth (1Y)
-1.94%
Revenue / Employee
$104,770
Profits / Employee
-$79,199
Market Cap
32.91M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 758 | -15 | -1.94% |
| Mar 31, 2023 | 773 | -92 | -10.64% |
| Mar 31, 2022 | 865 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
LSB News
- 3 months ago - LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance - PRNewsWire
- 4 months ago - LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China - GlobeNewsWire
- 5 months ago - LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement - PRNewsWire
- 5 months ago - LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine - PRNewsWire
- 6 months ago - LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance - PRNewsWire
- 6 months ago - LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation - PRNewsWire
- 7 months ago - Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024 - PRNewsWire
- 7 months ago - LakeShore Biopharma Announces Leadership Transitions - PRNewsWire